Question 1

Has Benjamin Kramer, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,088 in general payments to Benjamin Kramer, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Benjamin Kramer, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Benjamin Kramer, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
US Retina LLC	12	$814
Oyster Point Pharma, Inc.	3	$71
Dompe US, Inc.	2	$48
Sun Pharmaceutical Industries Inc.	2	$46
Glaukos Corporation	1	$33
Amgen	1	$31
Coopervision Inc.	1	$29
Rayner Intraocular Lenses Limited	1	$18

Benjamin Kramer, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other ophthalmology in Charlotte